View All Principal Researchers
Prevent Breast Cancer
Patient and Public Participation
Selected Publications - 2017
Selected Publications - 2016
IPVC Research Open Day
Annual Symposium 2016
The University of Manchester
Christie NHS Foundation Trust
Prevent Breast Cancer
St Mary's Hospital
Breast Cancer Now
Manchester scientists given funding to research how to stop breast cancer spreading to bone
13 October 2017
University of Manchester scientist Dr Robert Clarke was given the grant by Breast Cancer Now on Secondary Breast Cancer Awareness Day and will use the grant of more than £195,000 for his research on breast cancer stem cells (BCSCs)
New test set to transform breast cancer prevention
09 October 2017
Women who have a family history of breast cancer are set to benefit from a new genetic test at Manchester University NHS Foundation Trust
Manchester scientist to study how ‘hibernating’ breast cancer cells evade treatment
12 July 2017
A leading Manchester scientist has been awarded a grant worth over £185,000 by Breast Cancer Now to investigate how breast cancer cells are able to hibernate for years before returning elsewhere in the body.
Inbuilt Body Clocks Link Breast Stiffness to Cancer Risks
31 January 2017
University of Manchester biologists have discovered that breast tissues have 24-hour body clocks, and that several hundred genes are regulated in a daily cycle.
University of Manchester Minute Lectures Series
04 July 2016
Take a look at the work being done in our Manchester Breast Centre affiliated labs
Could 5:2 diet play a role in preventing breast cancer?
17 June 2016
"Women who follow the 5:2 diet 'could reduce their risk of breast cancer','' the Mail Online reports.
Artist joins forces with Manchester Breast Centre to create new project to support breast cancer
08 April 2016
A Wilmslow artist has created a new project which she hopes will empower those battling breast cancer.
Combination of lapatinib and trastuzumab shrinks HER2 positive breast cancer significantly in 11 days after diagnosis
11 March 2016
Approximately a quarter of women with HER2 positive breast cancer, who were treated with a combination of the targeted drugs lapatinib and trastuzumab before surgery and chemotherapy, saw their tumours shrink significantly or even disappear, according to results from a Manchester-led trial.
Delving deeper into breast density
03 March 2016
Researchers in Manchester have been exploring the causes of high breast density – a known risk factor for breast cancer – that could reveal new ways to prevent the disease.
Breast screening recommendation for women with cancer-causing syndrome
07 December 2015
Researchers in Manchester have found that women with an inherited genetic syndrome are at increased risk of developing breast cancer and should be considered for earlier screening.
Manchester breast cancer clinic attributes increased uptake of double mastectomies to Angelina Jolie effect
24 November 2015
Researchers at a breast cancer prevention clinic in Manchester have observed an increased uptake of preventative double mastectomies since May 2013, when Angelina Jolie announced that she had undergone the procedure.
Cancer scientist appointed by President Obama visits Manchester
24 October 2015
Professor Max Wicha a leading breast cancer specialist from the University of Michigan, has been at The University of Manchester to discuss collaborations and deliver a keynote address to scientists.
Developing a gel that mimics human breast for cancer research
07 October 2015
Scientists at the Universities of Manchester and Nottingham have been funded to develop a gel that will match many of the biological structures of human breast tissue, to advance cancer research and reduce animal testing.
New approach found to tackle breast cancer hormone therapy resistance
17 September 2015
University of Manchester researchers funded by Breast Cancer Now have discovered a new explanation as to why women with oestrogen receptor positive (ER+) breast cancer develop resistance to hormone treatment, and a potential new approach to overcome the problem.
New drug combination shows promise for breaking breast cancer resistance
20 April 2015
Researchers from The University of Manchester working with drug development company Evgen Pharma, have developed a new combination of drugs which could overcome treatment resistance and relapse in breast cancer.
Potential for prediction of progression for early form of breast cancer
15 April 2015
Scientists in Manchester have identified a way to potentially predict which patients with an early form of breast cancer will experience disease progression.
Researchers identify new ways to drain cancer’s ‘fuel tank’
25 November 2014
Scientists at The University of Manchester have discovered a potential weakness in cancer’s ability to return or become resistant to treatment, by targeting the ‘fuel’ part of stem cells which allows tumours to grow.
18 January 2018
Daniel Rea - Breast Cancer Now Seminar
Institute of Cancer and Genomic Sciences - University of Birmingham
Manchester Breast Centre, The University of Manchester, Wilmslow Road, Manchester, M20 4BX. Royal Charter Number: RC000797
© 2016 Manchester Breast Centre